Thibaut du Fayet
Chief Executive Officer chez PHAXIAM THERAPEUTICS S.A.
Postes actifs de Thibaut du Fayet
Sociétés | Poste | Début | Fin |
---|---|---|---|
PHAXIAM THERAPEUTICS S.A. | Chief Executive Officer | 23/06/2023 | - |
Historique de carrière de Thibaut du Fayet
Anciens postes connus de Thibaut du Fayet
Sociétés | Poste | Début | Fin |
---|---|---|---|
STALLERGENES | Sales & Marketing | 01/01/2007 | 01/01/2008 |
BIOMÉRIEUX | Sales & Marketing | - | - |
PHERECYDES PHARMA | Chief Executive Officer | 15/12/2022 | - |
Chief Operating Officer | 07/04/2022 | 19/05/2022 | |
Corporate Officer/Principal | 19/05/2022 | - | |
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. engages in theresearch and development, and manufacture of immunotherapies for the treatment of oncology and infectious diseases. Its business scope includes biopharmaceutical technology development, technology transfer, and related technical advisory services. The company was founded on July 26, 2010 and is headquartered in Tianjin, China. | Director/Board Member | - | - |
TRANSGENE | Corporate Officer/Principal | - | - |
Sales & Marketing | 01/01/2008 | - |
Formation de Thibaut du Fayet
Brandeis University | Graduate Degree |
ESSEC Business School | Masters Business Admin |
Statistiques
Internationale
France | 7 |
Etats-Unis | 2 |
Chine | 2 |
Opérationnelle
Sales & Marketing | 3 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 2 |
Sectorielle
Health Technology | 6 |
Consumer Services | 3 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
TRANSGENE | Health Technology |
BIOMÉRIEUX | Health Technology |
PHAXIAM THERAPEUTICS S.A. | Health Technology |
Entreprise privées | 3 |
---|---|
Stallergenes SA
Stallergenes SA Pharmaceuticals: MajorHealth Technology Stallergenes SA is an international biopharmaceutical company, which engages in the manufacture and sale of pharmaceutical products for the treatment of allergy-related respiratory diseases. The company operates through the Allergen Immunotherapy segment, which provides products and services for the desensitization of allergy-related respiratory conditions. Its products include a range of sublingual route and subcutaneous route products for the treatment of respiratory diseases such as rhino-conjunctivitis, rhinitis, and allergic asthma. Stallergenes was founded in 1962 and is headquartered in Antony, France. | Health Technology |
Pherecydes Pharma SA
Pherecydes Pharma SA Pharmaceuticals: MajorHealth Technology Pherecydes Pharma SA is a biotechnology company, which engages in the research and development of anti-infective therapies based on the use of bacteriophages. It develops phage treatments of bacterial infections. The company was founded by Jerome Gabard and Manuel Gea in December 2006 and is headquartered in Romainville, France. | Health Technology |
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. engages in theresearch and development, and manufacture of immunotherapies for the treatment of oncology and infectious diseases. Its business scope includes biopharmaceutical technology development, technology transfer, and related technical advisory services. The company was founded on July 26, 2010 and is headquartered in Tianjin, China. | Commercial Services |
- Bourse
- Insiders
- Thibaut du Fayet
- Expérience